在患有AECOPD的患者中,基线症状评分和外围CD4CD8双阳性T细胞的预测值
Shiyi He1,2, Shiyu Wu1, Tianwei Chen1,3
1Department of Respiratory and Critical Care Medicine, Key Laboratory of Respiratory Disease of Ningbo, The First Affiliated Hospital of Ningbo University, Ningbo, China.
BMC pulmonary medicine
|November 29, 2023
概括
通过使用CD4+CD8+T细胞,COPD评估测试成绩和家庭氧气治疗的模型,可以更好地预测COPD恶化中的呼吸衰竭. 这种方法提供了个性化患者护理的稳定和可访问的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 医学统计 医学统计
背景情况:
- 在慢性阻塞性肺病 (COPD) 中,准确预测急性恶化对于量身定制患者治疗至关重要.
- 淋巴细胞子集作为COPD急性恶化 (AECOPD) 的预测因素的作用需要进一步研究.
研究的目的:
- 研究淋巴细胞子集在预测AECOPD结果中的预后价值.
- 开发和验证AECOPD患者呼吸衰竭的预测模型.
主要方法:
- 一项前性队列研究,涉及137名AECOPD患者 (51-79岁),随访2年.
- 分析淋巴细胞子集和基线症状得分 (COPD评估测试 - CAT) 以确定预后指标.
- 构建了呼吸衰竭的预测性诺莫格拉姆模型.
主要成果:
- 一个结合CAT得分,家庭氧气治疗和CD4+CD8+T细胞的模型显示了AECOPD中呼吸衰竭的强大预测性表现 (AUC=0.77).
- 诺莫格拉姆模型显示出良好的预测准确性,校准和临床实用性.
- 减少CD4+CD8+T细胞的比例与较差的结果相关.
结论:
- 纳米图模型结合家庭氧气治疗,CAT分数和CD4+CD8+T细胞是预测AECOPD呼吸衰竭的实用方法.
- CD4+CD8+T细胞是AECOPD的可靠,可访问和稳定的预测因素,不太容易受到主观偏见的影响.
- 这种模型可以进行个性化风险评估,并为AECOPD患者提供预防干预信息.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:13Sensitivity, Specificity, and Predicted Value
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...